TJX

TJX Companies
D

TJX

Arincen83/100B

TJX Companies executives and insider trading

Ernie L. Herrman sold 97,551 shares for 15.52M USD in 4 sales over the last twelve months, the last on 5 June 2026, and bought none on the open market.

Over the last twelve months TJX Companies's insiders sold 202,740 shares for 32.54M USD in 9 sales on the open market, and bought 0 shares in 0 purchases.

Insiders over the last twelve months

Insider sales
9
Shares sold
202,740
Value sold
32.54M USD
Insider purchases
0

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
0
0
1 month
0
0
3 months
0
0
6 months
27.71M USD
0
1 year
32.54M USD
0
2 years
32.54M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
Ernie L. Herrman CEOChief Executive Officer, President & Director6597,55115.52M USD—5 Jun 2026514,848
Carol Meyrowitz Executive Chairman7255,6249.10M USD—9 Jun 2026201,496
Kenneth Canestrari Senior EVP & Group President6431,4474.95M USD—3 Jun 2026107,781
Peter Benjamin Senior EVP & Group President6310,9261.80M USD—10 Jun 2026117,267
John Klinger Senior Executive Vice President & Chief Financial Officer616,2351.00M USD—5 Jun 202664,257
Jackwyn Nemerov Director—957161.35K USD—11 Jun 2026802

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
11 Jun 2026Jackwyn NemerovSale957168.60161.35K USD802Form 4
10 Jun 2026Peter BenjaminSale10,926165.001.80M USD117,267Form 4
9 Jun 2026Carol MeyrowitzSale55,624163.659.10M USD201,496Form 4
5 Jun 2026John KlingerSale6,235160.771.00M USD64,257Form 4
5 Jun 2026Ernie L. HerrmanSale10,002160.681.61M USD514,848Form 4
4 Jun 2026Ernie L. HerrmanSale28,000158.334.43M USD524,850Form 4
3 Jun 2026Kenneth CanestrariSale31,447157.504.95M USD107,781Form 4
3 Jun 2026Ernie L. HerrmanSale29,549157.464.65M USD552,850Form 4
2 Mar 2026Ernie L. HerrmanSale30,000160.954.83M USD479,316Form 4

Common questions about TJX Companies's executives and insiders

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.